Condition: Breast Cancer · Sponsor: University Hospital, Tours
Despite pharmaceutical innovations, chemotherapy induced nausea is frequent and largely participating to alter our patients quality of life. Non invasive vagal stimulation is approved in other health issues, for example in headache or gastroparesis, with a reported benefit on nausea. This study aims to analyse if a non invasive vagal stimulation could better prevent chemotherapy induced nausea, in addition to standard treatment, in breast cancer patients treated with cyclophosphamide and anthracycline.
This description comes directly from the study's public registry record.
Mathilde CANCEL, MD · 02 47 47 99 19 · m.cancel@chu-tours.fr
Always discuss trial participation with your own doctor first.
| CH BLOIS | Blois, France | Active Not Recruiting |
| Chru Morvan | Brest, France | Recruiting |
| CORT37 | Chambray-lès-Tours, France | Recruiting |
| Ch Chateauroux | Châteauroux, France | Recruiting |
| Clinique Victor Hugo | Le Mans, France | Recruiting |
| Ch Orleans | Orléans, France | Active Not Recruiting |
| Ch Chinon | Saint-Benoît-la-Forêt, France | Recruiting |
| CHRU Bretonneau | Tours, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04937309